Central Maine Medical Center

Central Maine Medical Center was paid $76.13M by Medicaid between Jan 2018 and Dec 2024, across 692 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 21% of everything it billed.

33Billing provider infoCENTRAL MAINE MEDICAL CENTER
LEWISTON, ME 04240

33aNPI1689653487assigned 01/11/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$76.13M

24GClaims2,486,320

24DCodes billed692

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Maine

Rank by total paid#3 of 33

Median peer was paid$4.34M

This provider vs. median18×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	330,649	$8.74M
2019	365,478	$10.46M
2020	317,159	$9.63M
2021	371,451	$11.48M
2022	381,752	$11.39M
2023	382,617	$11.87M
2024incomplete	337,214	$12.55M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	21%	294,170	229,314	$16.26M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	11%	63,600	58,700	$8.62M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	7.5%	24,894	22,067	$5.73M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.0%	46,422	43,106	$4.58M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	5.3%	113,344	107,400	$4.02M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	2.5%	74,562	70,525	$1.87M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.2%	18,170	15,592	$1.70M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	2.0%	6,735	6,430	$1.53M
A0427	Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)	1.8%	7,433	6,467	$1.37M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.3%	8,462	7,852	$1.03M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.3%	15,733	14,832	$983K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.2%	10,277	9,973	$918K

680 more codes

96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	8,788	$733K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,362	$667K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,869	$666K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	18,881	$592K
71046	Radiologic examination, chest; 2 views	<1%	17,755	$577K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	29,219	$561K
70450	Computed tomography, head or brain; without contrast material	<1%	7,186	$550K
90834	Psychotherapy session, about 45 minutes	<1%	8,043	$545K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	4,241	$523K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	9,097	$501K
96375	Therapeutic injection; each additional sequential IV push	<1%	15,218	$452K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	5,060	$452K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	965	$448K
A0425	Ground mileage, per statute mile	<1%	14,811	$442K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	8,166	$425K
59025	Fetal non-stress test	<1%	3,406	$424K
99232	Hospital visit by a doctor, follow-up day	<1%	16,858	$404K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	7,214	$403K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	6,308	$343K
76819	Fetal biophysical profile; without non-stress testing	<1%	6,163	$340K
A0429	Emergency ambulance ride, basic life support	<1%	2,066	$322K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	5,925	$317K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	<1%	4,542	$311K
90832	Psychotherapy session, about 30 minutes	<1%	4,634	$305K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,707	$295K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	4,999	$292K
96361	Intravenous infusion, hydration; each additional hour	<1%	10,082	$276K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,987	$275K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,298	$275K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	4,856	$273K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	9,530	$271K
77386		<1%	1,120	$250K
Q3014	Telehealth originating site facility fee	<1%	16,567	$241K
99204	Doctor's office visit, new patient (more involved)	<1%	4,396	$240K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	4,810	$240K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	17,550	$236K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	3,198	$231K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,210	$224K
93975		<1%	1,467	$219K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	656	$217K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,518	$217K
52000		<1%	1,276	$205K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,655	$201K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,070	$200K
97161		<1%	6,125	$198K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	5,995	$198K
99215	Doctor's office visit, returning patient (complex)	<1%	3,916	$191K
77412		<1%	2,203	$182K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,842	$177K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	4,769	$171K
94060		<1%	2,451	$170K
84443	Thyroid stimulating hormone (TSH)	<1%	27,361	$168K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,116	$162K
80061	Lipid panel	<1%	23,903	$161K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	39,358	$157K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	78	$156K
76830	Ultrasound, transvaginal	<1%	2,314	$156K
20610		<1%	3,892	$153K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,300	$153K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	5,224	$151K
90791	Psychiatric diagnostic evaluation	<1%	1,793	$147K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	180	$146K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	9,479	$146K
80053	Comprehensive metabolic panel	<1%	80,571	$145K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	5,681	$138K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	486	$135K
77336		<1%	2,806	$134K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	9,904	$133K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	9,518	$129K
76801		<1%	1,897	$129K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	9,517	$128K
90461		<1%	5,561	$127K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	703	$124K
72141		<1%	993	$123K
99203	Doctor's office visit, new patient (routine)	<1%	3,393	$122K
43235		<1%	365	$118K
71045	Radiologic examination, chest; single view	<1%	3,964	$105K
95811		<1%	407	$104K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	5,605	$99K
93971		<1%	2,110	$99K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	4,189	$96K
97803		<1%	3,540	$90K
99223	Prolong inpt eval add15 m	<1%	1,533	$89K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,025	$89K
99336		<1%	2,639	$87K
90686		<1%	12,209	$83K
71250		<1%	2,186	$82K
96367		<1%	2,390	$80K
83036	Hemoglobin; glycosylated (A1C)	<1%	28,733	$79K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,048	$79K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	552	$79K
31575		<1%	1,236	$79K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	73,285	$78K
72100		<1%	3,219	$76K
70496		<1%	822	$76K
76642		<1%	1,860	$74K
80055		<1%	2,148	$74K
36415	Collection of venous blood by venipuncture	<1%	85,528	$72K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,385	$69K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,373	$67K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	289	$63K
92557		<1%	1,396	$61K
92587		<1%	567	$60K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	3,411	$55K
93017		<1%	1,380	$54K
31237		<1%	56	$52K
00731		<1%	1,663	$52K
98928		<1%	5,584	$51K
99239	Hospital discharge day management, more than 30 minutes	<1%	1,270	$51K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	7,662	$50K
77334		<1%	195	$50K
77427		<1%	782	$50K
82728		<1%	9,007	$48K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	3,389	$47K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	5,755	$46K
85027		<1%	26,831	$46K
93880		<1%	707	$45K
81511		<1%	496	$45K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	35,777	$45K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	1,836	$44K
88142		<1%	5,273	$44K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,930	$42K
A0434	Specialty care transport (sct)	<1%	104	$42K
77066	Tomosynthesis, mammo	<1%	581	$41K
43249		<1%	92	$40K
77300		<1%	194	$39K
29581		<1%	596	$38K
90677		<1%	1,052	$38K
70486		<1%	902	$38K
97165		<1%	1,934	$38K
82607		<1%	7,400	$38K
86480		<1%	1,229	$38K
71271		<1%	694	$36K
74018		<1%	1,507	$36K
99349		<1%	1,006	$36K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	3,646	$36K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	12,800	$36K
86803		<1%	5,662	$35K
97802		<1%	721	$35K
10060		<1%	320	$34K
76536		<1%	612	$34K
64450		<1%	76	$33K
72050		<1%	863	$33K
87510		<1%	7,077	$33K
0001A		<1%	2,041	$33K
87660		<1%	7,076	$33K
93970		<1%	353	$33K
87088		<1%	16,707	$33K
87480		<1%	7,079	$33K
96127		<1%	1,912	$33K
0002A		<1%	1,911	$33K
73630		<1%	4,485	$33K
86900		<1%	3,640	$31K
99205	Prolong outpt/office vis	<1%	368	$31K
99406		<1%	2,305	$30K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,644	$30K
36561		<1%	38	$29K
83655		<1%	2,995	$29K
36569		<1%	117	$29K
96415		<1%	793	$29K
74183		<1%	174	$29K
93922		<1%	1,554	$28K
73030		<1%	3,481	$28K
73502		<1%	2,736	$26K
82746		<1%	4,732	$25K
95806		<1%	448	$24K
31231		<1%	296	$23K
93923		<1%	644	$23K
97162		<1%	842	$23K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	1,885	$22K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	89	$22K
83970		<1%	1,417	$22K
73562		<1%	3,477	$21K
90792	Psychiatric diagnostic evaluation with medical services	<1%	313	$21K
J0897	Injection, denosumab, 1 mg	<1%	41	$21K
86703		<1%	3,133	$21K
95886		<1%	2,102	$21K
84439		<1%	6,290	$21K
73610		<1%	3,140	$20K
84702		<1%	3,383	$20K
69210		<1%	2,070	$20K
94010		<1%	2,524	$20K
99443		<1%	838	$20K
73130		<1%	2,777	$20K
77065	Tomosynthesis, mammo	<1%	412	$20K
83550		<1%	5,891	$19K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	16,172	$19K
58301		<1%	123	$18K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	2,316	$18K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	26	$18K
G0432	Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening	<1%	2,408	$18K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	794	$17K
83540		<1%	6,772	$17K
0004A		<1%	832	$17K
77080		<1%	585	$17K
80048	Basic metabolic panel (calcium, ionized)	<1%	10,796	$17K
77014		<1%	1,092	$17K
90651		<1%	1,466	$17K
70491		<1%	172	$16K
J1453	Injection, fosaprepitant, 1 mg	<1%	269	$16K
87522	Neg quan hep c or qual rna	<1%	745	$16K
72110		<1%	897	$16K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	189	$15K
97535	Self-care/home management training, each 15 minutes	<1%	1,651	$15K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	32	$15K
73560		<1%	1,177	$15K
73110		<1%	2,278	$15K
73221		<1%	125	$15K
90732		<1%	273	$14K
58300		<1%	363	$14K
90670		<1%	4,454	$14K
87340		<1%	3,230	$14K
99222	Initial hospital care, per day, moderate complexity	<1%	289	$14K
83735		<1%	14,038	$14K
99188		<1%	1,272	$14K
92567		<1%	3,236	$13K
95816		<1%	225	$13K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	51	$13K
83516		<1%	1,900	$13K
64615		<1%	108	$13K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	41	$13K
49083		<1%	29	$12K
86140		<1%	8,581	$12K
82565		<1%	13,723	$12K
17110		<1%	268	$12K
72070		<1%	400	$12K
86003		<1%	294	$12K
82105		<1%	1,335	$11K
93296		<1%	1,429	$11K
84481		<1%	1,798	$11K
82947		<1%	6,544	$11K
86704		<1%	2,322	$11K
76775		<1%	373	$11K
99442		<1%	633	$11K
85610		<1%	20,363	$10K
87081		<1%	4,962	$10K
80069		<1%	4,722	$10K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	157	$10K
86038		<1%	1,872	$10K
74221		<1%	131	$10K
G0296	Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)	<1%	727	$10K
90837	Psychotherapy session, about an hour	<1%	89	$9K
96158		<1%	211	$9K
90473		<1%	205	$9K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	407	$9K
82950		<1%	2,233	$9K
86592		<1%	2,916	$9K
36591		<1%	768	$9K
87186		<1%	5,856	$9K
96417		<1%	277	$9K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	634	$9K
90678		<1%	33	$9K
86706		<1%	1,650	$9K
80299		<1%	2,474	$9K
84153		<1%	1,183	$9K
80051		<1%	9,890	$9K
84425		<1%	687	$9K
87070		<1%	4,246	$9K
G0008	Administration of influenza virus vaccine	<1%	4,156	$9K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	3,146	$8K
98927		<1%	1,804	$8K
84403		<1%	549	$8K
0011A		<1%	535	$8K
84460		<1%	4,716	$8K
81001		<1%	21,111	$8K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	245	$8K
99385		<1%	110	$8K
11981		<1%	106	$8K
85651		<1%	7,185	$8K
81025		<1%	13,297	$8K
83880		<1%	4,960	$7K
0071A		<1%	196	$7K
84450		<1%	4,786	$7K
64483		<1%	73	$7K
90656		<1%	905	$7K
84520		<1%	11,781	$7K
86618		<1%	1,495	$7K
95913		<1%	65	$7K
88342		<1%	2,092	$7K
99348		<1%	216	$6K
80076		<1%	1,593	$6K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	543	$6K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,946	$6K
87581		<1%	5,757	$6K
90662		<1%	1,808	$6K
91200		<1%	109	$6K
86850		<1%	3,641	$6K
20551		<1%	132	$5K
70498		<1%	841	$5K
82043		<1%	3,806	$5K
86708		<1%	920	$5K
29075		<1%	84	$5K
84100		<1%	3,071	$5K
0072A		<1%	131	$5K
93229		<1%	606	$5K
95251		<1%	492	$5K
87147		<1%	3,533	$5K
73080		<1%	742	$4K
85018		<1%	4,148	$4K
87641		<1%	287	$4K
82247		<1%	2,217	$4K
76770		<1%	54	$4K
83021		<1%	246	$4K
82784		<1%	1,378	$4K
95819		<1%	25	$4K
88307		<1%	856	$4K
84146		<1%	346	$4K
93280		<1%	535	$4K
96150		<1%	37	$4K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	184	$4K
87536		<1%	179	$4K
74178		<1%	53	$4K
93798		<1%	80	$4K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	230	$4K
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	483	$4K
82248		<1%	2,920	$4K
86317		<1%	212	$4K
82570		<1%	1,672	$3K
81003		<1%	11,008	$3K
84270		<1%	250	$3K
90734		<1%	1,787	$3K
77062		<1%	62	$3K
0031A		<1%	176	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	4,679	$3K
83690		<1%	13,607	$3K
87640		<1%	299	$3K
87077		<1%	4,184	$3K
93926		<1%	119	$3K
97116		<1%	570	$3K
83001		<1%	337	$3K
96156		<1%	64	$3K
73564		<1%	671	$3K
85730		<1%	3,357	$3K
99308	Subsequent nursing facility care, per day, straightforward	<1%	161	$3K
84446		<1%	353	$3K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	149	$3K
84590		<1%	399	$3K
72040		<1%	216	$3K
93225		<1%	68	$3K
84597		<1%	310	$3K
87205		<1%	3,573	$3K
83993		<1%	192	$3K
99335		<1%	87	$3K
73140		<1%	330	$3K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	212	$3K
86431		<1%	1,175	$2K
73590		<1%	507	$2K
0124A		<1%	253	$2K
92582		<1%	30	$2K
82670		<1%	134	$2K
84075		<1%	1,579	$2K
99383		<1%	36	$2K
90716		<1%	1,191	$2K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	172	$2K
86160		<1%	463	$2K
93976		<1%	39	$2K
92579		<1%	112	$2K
11720		<1%	346	$2K
82274		<1%	331	$2K
43248		<1%	12	$2K
86376		<1%	319	$2K
94729		<1%	2,251	$2K
93295		<1%	151	$2K
72131		<1%	89	$2K
84156		<1%	1,469	$2K
94726		<1%	499	$2K
74174		<1%	16	$2K
87209		<1%	144	$2K
0064A		<1%	158	$2K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	448	$2K
84480		<1%	290	$2K
G0127	Trimming of dystrophic nails, any number	<1%	652	$2K
98926		<1%	518	$2K
84165		<1%	609	$2K
11056		<1%	88	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	16,523	$2K
G0250	Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests	<1%	2,285	$2K
51705		<1%	29	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	9,516	$2K
87625		<1%	109	$2K
82040		<1%	1,909	$1K
90620		<1%	88	$1K
99397		<1%	168	$1K
93308		<1%	148	$1K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	962	$1K
99177		<1%	224	$1K
77280		<1%	28	$1K
90649		<1%	808	$1K
82550		<1%	1,278	$1K
51798		<1%	2,605	$1K
90480		<1%	62	$1K
80164		<1%	394	$1K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	11,119	$1K
84703		<1%	1,553	$1K
87046		<1%	119	$1K
99496		<1%	39	$1K
64405		<1%	12	$1K
99292		<1%	19	$1K
93271		<1%	13	$1K
97035		<1%	286	$1K
88720		<1%	282	$1K
83520		<1%	180	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	18,431	$1K
74230		<1%	28	$1K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	12,269	$1K
72170		<1%	134	$1K
92552		<1%	12	$1K
83605		<1%	6,613	$1K
81002		<1%	3,455	$1K
J0690	Injection, cefazolin sodium, 500 mg	<1%	3,975	$1K
A0426	Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)	<1%	12	$1K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	96	$1K
G0378	Hospital observation service, per hour	<1%	6,274	$1K
96523		<1%	54	$1K
93351		<1%	25	$1K
88304		<1%	1,357	$999.44
87177		<1%	144	$984.02
72146		<1%	12	$966.59
73090		<1%	221	$958.84
84630		<1%	146	$952.85
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	11,399	$950.50
J3490	Unclassified drugs	<1%	2,293	$929.92
76882		<1%	39	$927.25
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	6,808	$912.80
84160		<1%	607	$907.01
90673		<1%	94	$874.53
99441		<1%	97	$868.38
86787		<1%	79	$867.21
93270		<1%	83	$862.90
86255		<1%	118	$862.27
85045		<1%	741	$856.37
99310	Prolong nursin fac eval 15m	<1%	16	$854.27
93016		<1%	79	$848.20
96380		<1%	55	$847.00
85380		<1%	3,142	$844.24
82525		<1%	114	$807.79
83615		<1%	922	$799.13
85014		<1%	2,017	$794.33
G0180	Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care	<1%	148	$792.09
87040		<1%	3,983	$771.61
96376		<1%	4,748	$768.98
86352		<1%	2,119	$761.89
G0009	Administration of pneumococcal vaccine	<1%	314	$761.48
83883		<1%	172	$746.23
99347		<1%	58	$726.87
99221		<1%	27	$720.30
84550		<1%	530	$712.67
99337		<1%	14	$712.08
76870		<1%	69	$703.14
99350	Prolong home eval add 15m	<1%	14	$689.32
97166		<1%	26	$687.84
84132		<1%	599	$685.77
82310		<1%	639	$669.92
94727		<1%	925	$667.99
87427		<1%	105	$661.20
17250		<1%	36	$657.80
87493		<1%	58	$644.00
90619		<1%	451	$633.88
87045		<1%	119	$591.97
82805		<1%	2,011	$583.34
99152		<1%	2,674	$567.51
93018		<1%	79	$563.64
90681		<1%	2,355	$560.90
73700		<1%	14	$550.57
84484		<1%	14,252	$548.98
82977		<1%	168	$544.35
91320		<1%	31	$530.04
86923		<1%	56	$513.70
93246		<1%	28	$498.01
93283		<1%	26	$496.37
51702		<1%	26	$482.14
90682		<1%	15	$473.65
82785		<1%	71	$455.68
D1206	Topical application of fluoride varnish	<1%	46	$453.75
86665		<1%	27	$438.30
73552		<1%	97	$433.11
92611		<1%	25	$427.98
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,622	$424.61
82533		<1%	68	$422.64
83002		<1%	47	$417.51
93289		<1%	40	$401.24
99173		<1%	187	$400.18
88300		<1%	668	$374.26
85049		<1%	374	$367.76
86200		<1%	92	$356.79
86361		<1%	107	$353.33
11721		<1%	24	$351.83
74019		<1%	32	$351.04
99495		<1%	13	$331.01
G0400	Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels	<1%	14	$330.86
93288		<1%	14	$329.11
72128		<1%	12	$324.46
99305		<1%	12	$277.56
00811		<1%	12	$268.44
92610		<1%	24	$262.22
97605		<1%	22	$254.09
G0179	Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care	<1%	89	$232.72
80177		<1%	56	$211.04
84134		<1%	32	$210.50
92551		<1%	25	$207.50
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	14	$205.31
93325		<1%	207	$203.71
C1769	Guide wire	<1%	3,139	$190.88
82951		<1%	18	$179.18
86334		<1%	28	$177.74
86705		<1%	25	$176.55
82150		<1%	113	$174.67
86225		<1%	27	$174.61
87338		<1%	24	$173.95
90723		<1%	2,105	$168.13
73060		<1%	32	$165.62
82172		<1%	31	$165.18
82272		<1%	421	$157.18
93294		<1%	33	$155.78
93352		<1%	12	$151.62
86901		<1%	3,642	$150.08
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	2,954	$146.09
93321		<1%	73	$143.20
73100		<1%	84	$141.91
36416		<1%	15,681	$141.14
90744		<1%	200	$138.44
99153	Mod sedat endo service >5yrs	<1%	1,362	$135.89
81000		<1%	467	$131.64
J7030	Infusion, normal saline solution , 1000 cc	<1%	13,028	$124.62
12001		<1%	481	$119.64
86039		<1%	28	$117.03
86762		<1%	12	$116.18
84681		<1%	15	$115.90
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	3,287	$112.86
82962		<1%	2,767	$109.75
86664		<1%	12	$102.27
82010		<1%	876	$101.02
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	1,195	$100.72
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,057	$100.30
96402		<1%	16	$99.33
74022		<1%	14	$92.58
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	348	$92.38
86765		<1%	15	$91.69
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	355	$90.89
86709		<1%	12	$90.08
71101		<1%	13	$89.59
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	30	$86.44
93226		<1%	68	$85.94
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,150	$85.03
36600		<1%	27	$84.63
84295		<1%	50	$80.44
0003A		<1%	13	$80.02
76937		<1%	2,845	$72.69
84155		<1%	127	$68.10
90715		<1%	5,975	$67.94
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	930	$66.44
J1644	Injection, heparin sodium, per 1000 units	<1%	4,735	$65.19
86308		<1%	82	$63.12
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	42	$61.86
87634		<1%	72	$60.66
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	5,494	$60.15
87207		<1%	63	$59.90
87807		<1%	154	$49.75
12011		<1%	54	$47.84
82140		<1%	37	$43.71
J7999	Compounded drug, not otherwise classified	<1%	980	$43.56
J2270	Injection, morphine sulfate, up to 10 mg	<1%	3,223	$41.56
88108		<1%	24	$41.09
82952		<1%	18	$40.66
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	1,997	$40.18
82374		<1%	27	$40.14
0012A		<1%	95	$40.01
82435		<1%	28	$37.77
86800		<1%	15	$28.50
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,816	$22.06
88302		<1%	53	$21.24
98929		<1%	12	$20.22
83721		<1%	12	$19.34
J2060	Injection, lorazepam, 2 mg	<1%	3,000	$13.33
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	406	$11.67
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	975	$10.06
J1790	Injection, droperidol, up to 5 mg	<1%	284	$4.50
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	42	$4.44
90672		<1%	13	$0.13
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	29	$0.02
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	693	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	1,617	$0.00
77417		0%	76	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	12	$0.00
90696		0%	912	$0.00
90647		0%	2,473	$0.00
96368		0%	103	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	643	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	283	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	212	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	1,019	$0.00
90698		0%	115	$0.00
J7050	Infusion, normal saline solution, 250 cc	0%	604	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	570	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	331	$0.00
36410		0%	723	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	208	$0.00
91306		0%	65	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	217	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	395	$0.00
91303		0%	98	$0.00
88341		0%	788	$0.00
91307		0%	332	$0.00
94760		0%	959	$0.00
90697		0%	1,108	$0.00
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	0%	15	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	168	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	163	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	258	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	298	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	56	$0.00
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	29	$0.00
G8991	Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	389	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	614	$0.00
77001		0%	157	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	44	$0.00
A4648	Tissue marker, implantable, any type, each	0%	45	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	59	$0.00
J8597	Antiemetic drug, oral, not otherwise specified	0%	652	$0.00
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	0%	14	$0.00
93320		0%	14	$0.00
G8992	Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting	0%	15	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	48	$0.00
91301		0%	682	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	13	$0.00
J1250	Injection, dobutamine hydrochloride, per 250 mg	0%	29	$0.00
J9045	Injection, carboplatin, 50 mg	0%	25	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	70	$0.00
L3924	Hand finger orthosis, without joints, may include soft interface, straps, prefabricated, off-the-shelf	0%	14	$0.00
94761		0%	103	$0.00
90381		0%	45	$0.00
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	0%	14	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	112	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	580	$0.00
90707		0%	1,158	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	2,096	$0.00
90633		0%	2,806	$0.00
91300		0%	4,793	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	654	$0.00
90648		0%	88	$0.00
90472	Immunization administration, each additional vaccine (list separately)	0%	5,013	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	913	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	1,213	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	23	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	700	$0.00
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	130	$0.00
90700		0%	1,216	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	802	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	140	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	1,864	$0.00
90710		0%	1,385	$0.00
C1776	Joint device (implantable)	0%	27	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	259	$0.00
90685		0%	691	$0.00
C1788	Port, indwelling (implantable)	0%	38	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	592	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	535	$0.00
88173		0%	41	$0.00
93356		0%	42	$0.00
G8990	Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals	0%	298	$0.00
76376		0%	113	$0.00
J1020	Injection, methylprednisolone acetate, 20 mg	0%	27	$0.00
91312		0%	237	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	130	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	264	$0.00
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	0%	80	$0.00
C1729	Catheter, drainage	0%	287	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	100	$0.00
88360		0%	24	$0.00
82800		0%	71	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	55	$0.00
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	0%	16	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	50	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	37	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	28	$0.00
J2550	Injection, promethazine hcl, up to 50 mg	0%	14	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	14	$0.00
90713		0%	27	$0.00
91308		0%	16	$0.00
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMORIN, SUSAN (REGIONAL MANAGER PHYSICIAN PRACTICE)

Same official

Other billing entities under MORIN, SUSAN

Full network →

Provider	Location	Paid
Central Maine Clinical Associates Corporation	Lewiston, ME	$525K
Susan D Morin	Woonsocket, RI	$17K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.